Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays

被引:14
作者
Bauer, R.
Wild, P. J.
Meyer, S.
Bataille, F.
Pauer, A.
Klinkhammer-Schalke, M.
Hofstaedter, F.
Bosserhoff, A. K.
机构
[1] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany
[2] Cent Tumor Registry, Regensburg, Germany
关键词
D O I
10.1136/jcp.2005.034538
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim: To investigate whether protein expression or cellular localisation of P-cadherin is associated with clinicopathological characteristics in benign and malignant melanocytic skin tumours. Experimental design: P-cadherin expression and the Ki-67 labelling index were analysed immunohistochemically by using tissue microarrays (TMAs). Membranous and cytoplasmic expression was scored semiquantitatively (0 to 2+). Results: P-cadherin protein expression of any intensity (1+ to 2+) was detected in the membrane in 41.5% (132/318) and in the cytoplasm in 64.2% (204/318) of patients. In general, P-cadherin expression was significantly reduced in malignant melanomas (p < 0.001) and melanoma metastases (p < 0.001), compared with benign nevi. Additionally, loss of membranous P-cadherin was associated with Clark level (p = 0.011) and tumour thickness (p < 0.001). Interestingly, a significantly lower P-cadherin expression was shown by dermal nevi than by compound and junctional nevi (p = 0.005; p = 0.025). In primary melanomas, a Ki-67 labelling index < 5% was not associated with P-cadherin protein expression, suggesting that loss of P-cadherin expression was not associated with proliferation. None of the other clinical and histological factors analysed was significantly related to P-cadherin expression. Low cytoplasmic P-cadherin expression was associated with tumour recurrence (p = 0.03) in all the patients who were analysed. After testing various multivariate Cox regression models, loss of cytoplasmic P-cadherin expression remained a highly significant adverse risk factor for tumour recurrence in patients with tumours < 2 mm. Conclusions: Loss of cytoplasmic P-cadherin expression is common in advanced melanomas and can be a prognostic marker of progression in patients with melanoma, most useful in patients with primary tumours < 2 mm in thickness.
引用
收藏
页码:699 / 705
页数:7
相关论文
共 24 条
[1]   Progression in cutaneous malignant melanoma is associated with distinct expression profiles -: A tissue microarray-based study [J].
Alonso, SR ;
Ortiz, P ;
Pollán, M ;
Pérez-Gómez, B ;
Sánchez, L ;
Acuña, MJ ;
Pajares, R ;
Martínez-Tello, FJ ;
Hortelano, CM ;
Piris, MA ;
Rodríguez-Peralto, JL .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :193-203
[2]   A secreted form of P-cadherin is expressed in malignant melanoma [J].
Bauer, R ;
Hein, R ;
Bosserhoff, AK .
EXPERIMENTAL CELL RESEARCH, 2005, 305 (02) :418-426
[3]   Characterization of methylthioadenosin, phosphorylase (MTAP) expression in malignant melanoma [J].
Behrmann, I ;
Wallner, S ;
Komyod, W ;
Heinrich, PC ;
Schuierer, M ;
Buettner, R ;
Bosserhoff, AK .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (02) :683-690
[4]   CLONING AND CHARACTERIZATION OF THE HUMAN INVASION SUPPRESSOR GENE E-CADHERIN (CDH1) [J].
BERX, G ;
STAES, K ;
VANHENGEL, J ;
MOLEMANS, F ;
BUSSEMAKERS, MJG ;
VANBOKHOVEN, A ;
VANROY, F .
GENOMICS, 1995, 26 (02) :281-289
[5]   Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma [J].
Bogenrieder, T ;
Herlyn, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 44 (01) :1-15
[6]   Biornarkers in melanoma: staging, prognosis and detection of early metastases [J].
Carlson, JA ;
Slominski, A ;
Linette, GP ;
Mihm, MC ;
Ross, JS .
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2003, 3 (03) :303-330
[7]   Prognostic significance of activated Akt expression in melanoma: A clinicopathologic study of 292 cases [J].
Dai, DL ;
Martinka, M ;
Li, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1473-1482
[8]   Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma [J].
Farkas, B ;
Hantschel, M ;
Magyarlaki, M ;
Becker, B ;
Scherer, K ;
Landthaler, M ;
Pfister, K ;
Gehrmann, M ;
Gross, C ;
Mackensen, A ;
Multhoff, G .
MELANOMA RESEARCH, 2003, 13 (02) :147-152
[9]   E-CADHERIN-MEDIATED CELL CELL-ADHESION PREVENTS INVASIVENESS OF HUMAN CARCINOMA-CELLS [J].
FRIXEN, UH ;
BEHRENS, J ;
SACHS, M ;
EBERLE, G ;
VOSS, B ;
WARDA, A ;
LOCHNER, D ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1991, 113 (01) :173-185
[10]  
GUTMAN M, 1995, CANCER RES, V55, P2470